{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:01:17Z","timestamp":1776078077793,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Hunan Provincial Natural Science Foundation of China","award":["2021JJ40427"],"award-info":[{"award-number":["2021JJ40427"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s13258-024-01505-x","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T17:01:46Z","timestamp":1709571706000},"page":"437-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bioinformatics analysis and experimental validation reveal that CDC20 overexpression promotes bladder cancer progression and potential underlying mechanisms"],"prefix":"10.1007","volume":"46","author":[{"given":"Yuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-hui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-1172","authenticated-orcid":false,"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"113929","DOI":"10.1016\/j.biopha.2022.113929","volume":"156","author":"YR Chen","year":"2022","unstructured":"Chen YR, Wang SC, Huang SP, Su CC, Liu PL, Cheng WC, Chuu CP, Chen JK, Bao BY, Lee CH, Ke CC, Wu HE, Chang HH, Yeh HC, Li CY (2022) Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways. Biomed Pharmacother 156:113929","journal-title":"Biomed Pharmacother"},{"key":"1505_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00428-013-1473-6","volume":"463","author":"JW Choi","year":"2013","unstructured":"Choi JW, Kim Y, Lee JH, Kim YS (2013) High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer. Virchows Arch 463:681\u2013687","journal-title":"Virchows Arch"},{"key":"1505_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11912-023-01390-9","volume":"25","author":"DC Cockrell","year":"2023","unstructured":"Cockrell DC, Rose TL (2023) Current status of Perioperative Therapy in muscle-invasive bladder Cancer and future directions. Curr Oncol Rep 25:511\u2013520","journal-title":"Curr Oncol Rep"},{"key":"1505_CR4","doi-asserted-by":"crossref","unstructured":"Faulk A, Avulova S, Bree KK, Baak-Kukreja J, Westerman ME (2023) Pelvic organ preservation in non-muscle-invasive bladder Cancer: less is more. Eur Urol Focus","DOI":"10.1016\/j.euf.2023.04.006"},{"key":"1505_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00345-018-2436-y","volume":"37","author":"MI Fern\u00e1ndez","year":"2019","unstructured":"Fern\u00e1ndez MI, Brausi M, Clark PE, Cookson MS, Grossman HB, Khochikar M, Kiemeney LA, Malavaud B, Sanchez-Salas R, Soloway MS, Svatek RS, Vikram R, Vrieling A, Kamat AM (2019) Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer. World J Urol 37:3\u201313","journal-title":"World J Urol"},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4161\/epi.7.1.18545","volume":"7","author":"M Gonzalez","year":"2012","unstructured":"Gonzalez M, Li F (2012) DNA replication, RNAi and epigenetic inheritance. Epigenetics 7:14\u201319","journal-title":"Epigenetics"},{"key":"1505_CR8","first-page":"678","volume":"15","author":"W He","year":"2023","unstructured":"He W, Meng J (2023) CDC20: a novel therapeutic target in cancer. Am J Transl Res 15:678\u2013693","journal-title":"Am J Transl Res"},{"key":"1505_CR7","doi-asserted-by":"crossref","unstructured":"He S, Liu D, Chen Z (2022) REC8 inhibits proliferation, migration and invasion of breast cancer cells by targeting CDC20. Mol Med Rep 26","DOI":"10.3892\/mmr.2022.12751"},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"188824","DOI":"10.1016\/j.bbcan.2022.188824","volume":"1877","author":"SM Jeong","year":"2022","unstructured":"Jeong SM, Bui QT, Kwak M, Lee JY, Lee PC (2022) Targeting Cdc20 for cancer therapy. Biochim Biophys Acta Rev Cancer 1877:188824","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/sj.onc.1210799","volume":"27","author":"T Kidokoro","year":"2008","unstructured":"Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K (2008) CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene 27:1562\u20131571","journal-title":"Oncogene"},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.21037\/jgo-22-549","volume":"13","author":"W Li","year":"2022","unstructured":"Li W, Chen H, Wang Z, Liu J, Lei X, Chen W (2022) Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer. J Gastrointest Oncol 13:1058\u20131072","journal-title":"J Gastrointest Oncol"},{"key":"1505_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12967-023-04118-2","volume":"21","author":"J Li","year":"2023","unstructured":"Li J, Qi Y, Li B, Liu Y, Yang K, Zhang Z, Zhu J, Du E (2023) STIL\/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer. J Transl Med 21:281","journal-title":"J Transl Med"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"35e15","DOI":"10.1016\/j.urolonc.2013.01.009","volume":"32","author":"AJ Lightfoot","year":"2014","unstructured":"Lightfoot AJ, Breyer BN, Rosevear HM, Erickson BA, Konety BR, O\u2019Donnell MA (2014) Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer. Urol Oncol 32:35e15\u201335e19","journal-title":"Urol Oncol"},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, Gupta S, Smith AB, Williams SB, Lotan Y (2022) Epidemiology, screening, and Prevention of bladder Cancer. Eur Urol Oncol 5:628\u2013639","journal-title":"Eur Urol Oncol"},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.21037\/tau.2017.08.19","volume":"6","author":"A Mari","year":"2017","unstructured":"Mari A, D\u2019Andrea D, Abufaraj M, Foerster B, Kimura S, Shariat SF (2017) Genetic determinants for chemo- and radiotherapy resistance in bladder cancer. Transl Androl Urol 6:1081\u20131089","journal-title":"Transl Androl Urol"},{"key":"1505_CR16","doi-asserted-by":"crossref","unstructured":"Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y (2017) Bladder cancer. Nat Rev Dis PrimersNature reviews. Disease primers","DOI":"10.1038\/nrdp.2017.22"},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"103564","DOI":"10.1016\/j.sjbs.2023.103564","volume":"30","author":"H Sevim Nalkiran","year":"2023","unstructured":"Sevim Nalkiran H, Akcora Yildiz D, Saydam F, Guzel AI, Nalkiran I (2023) Targeting the anaphase-promoting complex\/cyclosome (APC\/C) enhanced antiproliferative and apoptotic response in bladder cancer. Saudi J Biol Sci 30:103564","journal-title":"Saudi J Biol Sci"},{"key":"1505_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2020.10.011","volume":"496","author":"M Shi","year":"2021","unstructured":"Shi M, Dai WQ, Jia RR, Zhang QH, Wei J, Wang YG, Xiang SH, Liu B, Xu L (2021) APC(CDC20)-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma. Cancer Lett 496:144\u2013155","journal-title":"Cancer Lett"},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"1505_CR20","doi-asserted-by":"crossref","unstructured":"Su Y, Wang B, Huang J, Huang M, Lin T (2023) YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer. Cell Prolif:e13404","DOI":"10.1111\/cpr.13404"},{"key":"1505_CR21","doi-asserted-by":"crossref","unstructured":"Verma S, Shankar E, Lin S, Singh V, Chan ER, Cao S, Fu P, MacLennan GT, Ponsky LE, Gupta S (2021) Identification of key genes Associated with progression and prognosis of bladder Cancer through Integrated Bioinformatics Analysis. Cancers (Basel) 13","DOI":"10.3390\/cancers13235931"},{"key":"1505_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pharmthera.2015.04.002","volume":"151","author":"L Wang","year":"2015","unstructured":"Wang L, Zhang J, Wan L, Zhou X, Wang Z, Wei W (2015) Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol Ther 151:141\u2013151","journal-title":"Pharmacol Ther"},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.omto.2020.03.011","volume":"17","author":"J Wang","year":"2020","unstructured":"Wang J, Yang S, Ji Q, Li Q, Zhou F, Li Y, Yuan F, Liu J, Tian Y, Zhao Y, Zheng Y (2020) Long non-coding RNA EPIC1 promotes cell proliferation and motility and Drug Resistance in Glioma. Mol Ther Oncolytics 17:130\u2013137","journal-title":"Mol Ther Oncolytics"},{"key":"1505_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.canlet.2020.11.052","volume":"500","author":"L Wang","year":"2021","unstructured":"Wang L, Yang C, Chu M, Wang ZW, Xue B (2021) Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation. Cancer Lett 500:172\u2013181","journal-title":"Cancer Lett"},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/ol.2023.13787","volume":"25","author":"N Wang","year":"2023","unstructured":"Wang N, Chen Y, Wu J (2023a) CCT6A is associated with CDC20, enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion. Oncol Lett 25:201","journal-title":"Oncol Lett"},{"key":"1505_CR26","doi-asserted-by":"crossref","unstructured":"Wang Q, Ke S, Liu Z, Shao H, He M, Guo J (2023b) HSPA5 promotes the Proliferation, Metastasis and regulates ferroptosis of bladder Cancer. Int J Mol Sci 24","DOI":"10.3390\/ijms24065144"},{"key":"1505_CR27","first-page":"3350","volume":"14","author":"J Weinstein","year":"1994","unstructured":"Weinstein J, Jacobsen FW, Hsu-Chen J, Wu T, Baum LG (1994) A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4. Mol Cell Biol 14:3350\u20133363","journal-title":"Mol Cell Biol"},{"key":"1505_CR28","doi-asserted-by":"publisher","first-page":"1017864","DOI":"10.3389\/fonc.2022.1017864","volume":"12","author":"F Xian","year":"2022","unstructured":"Xian F, Yang X, Xu G (2022) Prognostic significance of CDC20 expression in malignancy patients: a meta-analysis. Front Oncol 12:1017864","journal-title":"Front Oncol"},{"key":"1505_CR29","doi-asserted-by":"crossref","unstructured":"Xu Y, Wu G, Li J, Li J, Ruan N, Ma L, Han X, Wei Y, Li L, Zhang H, Chen Y, Xia Q (2020) Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data. Biomed Res Int 2020:8283401","DOI":"10.1155\/2020\/8283401"},{"key":"1505_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ebiom.2019.03.032","volume":"42","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Huang H, Liu A, Li J, Liu C, Sun B, Chen L, Gao Y, Xu D, Su C (2019) Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of \u03b2-catenin in cancer stem-like cells. EBioMedicine 42:397\u2013407","journal-title":"EBioMedicine"},{"key":"1505_CR30","doi-asserted-by":"crossref","unstructured":"Zhang C, Wang M, Ying Y, Meng F, Gao H, Zeng S, Zhu Y, Liu A, Zhang Z, Xu C (2023) Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells. Cancer Med","DOI":"10.1002\/cam4.5932"},{"key":"1505_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000489402","volume":"63","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Ding W, Weng Y, Ding G, Xia G, Xu J, Xu K, Ding Q (2018) NOS3 895G>T and CBR3 730G>A are Associated with recurrence risk in non-muscle-invasive bladder Cancer with Intravesical instillations of THP. Chemotherapy 63:191\u2013197","journal-title":"Chemotherapy"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-024-01505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-024-01505-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-024-01505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T12:30:13Z","timestamp":1711024213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-024-01505-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1007\/s13258-024-01505-x","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"25 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study used data from public databases and performed only in vitro cellular experiments, which did not involve the collection of human samples and therefore did not require ethical review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors have consented to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no direct confict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}